drugset / Trial / NCT04731623
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of ION904.
Timeline
- Start
- 2021-02-26
- Primary completion
- 2021-08-12
- Completion
- 2021-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tonlamarsen | Unknown | — | Subcutaneous |
Indications
No indication recorded.